Back to Journals » Infection and Drug Resistance » Volume 11

Original Research

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

       
Total article views   HTML views PDF downloads Totals
18,246 Dovepress* 13,859+ 1,418 15,277
PubMed Central* 4,387 368 4,755
Totals 18,246 1,786 20,032
*Since 25 May 2018
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar